Our work presents the first evidences that the E3 ligase activity of MKRN2 engages with β-Catenin ubiquitination and degradation, leading to Wnt inactivation in ccRCC settings. The gene discussed is MKRN2; the disease is nonpapillary renal cell carcinoma.